Axogen, Inc. Common Stock earnings per share and revenue
On Oct 29, 2025, AXGN reported earnings of 0.12 USD per share (EPS) for Q3 25, beating the estimate of 0.07 USD, resulting in a 64.16% surprise. Revenue reached 60.08 million, compared to an expected 57.94 million, with a 3.69% difference. The market reacted with a +23.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of 0.06 USD, with revenue projected to reach 59.69 million USD, implying an decrease of -50.00% EPS, and decrease of -0.65% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
FAQ
What were Axogen, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Axogen, Inc. Common Stock reported EPS of $0.12, beating estimates by 64.16%, and revenue of $60.08M, 3.69% above expectations.
How did the market react to Axogen, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 23.06%, changed from $18.08 before the earnings release to $22.25 the day after.
When is Axogen, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 23, 2026.
What are the forecasts for Axogen, Inc. Common Stock's next earnings report?
Based on 11
analysts, Axogen, Inc. Common Stock is expected to report EPS of $0.06 and revenue of $59.69M for Q4 2025.